Results 271 to 280 of about 4,735,099 (379)

MP07-17 CLINICAL VALIDATION OF A LIVE-CELL PHENOTYPIC BIOMARKER - BASED DIAGNOSTIC ASSAY FOR THE PREDICTION OF ADVERSE PATHOLOGY IN PROSTATE CANCER [PDF]

, 2016
David Albala, Vladimir Mouraviev, Kimberly Rieger‐Christ, Travis Sullivan, Naveen Kella, Kevin Knopf, Hani Rashid, Michael S. Manak, Brad J. Hogan, Gauri Dixit, Delaney Berger, Wendell R. Su, Matthew J. Whitfield, Jonathan S. Varsanik, Mani Foroohar, Stephen Zappala, Ashok C. Chander, Grannum R. Sant   +17 more
openalex   +1 more source

A micropattern-based assay to study contact inhibition of locomotion and entosis of adherent human and canine cells in vitro

, 2023
Mariel Flavia Schwietzer, Sonja Thölmann, Lilo Greune, Klaus Ebnet   +3 more
openalex   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Functional characterization of SORL1 variants in cell-based assays to investigate variant pathogenicity. [PDF]

Philos Trans R Soc Lond B Biol Sci
Fazeli E, Fazeli E, Fojtík P, Holstege H, Andersen OM.   +4 more
europepmc   +1 more source

Detection of MOG-IgG in Clinical Samples by Live Cell-Based Assays: Performance of Immunofluorescence Microscopy and Flow Cytometry. [PDF]

Front Immunol, 2021
Marchionatti A, Hansel G, Avila GU, Sato DK.   +3 more
europepmc   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source

Establishing a Relationship between In Vitro Potency in Cell-Based Assays and Clinical Efficacious Concentrations for Approved GLP-1 Receptor Agonists. [PDF]

Pharmaceutics
Boianelli A, Nordell P, Earl J, Naylor J, Hornigold D, Jansson Löfmark R, Sundqvist M.   +6 more
europepmc   +1 more source

Screening for lung cancer: A systematic review of overdiagnosis and its implications

Molecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz, Laura de la Torre‐Perez, David R Baldwin, Carlijn van der Aalst, Mangesh Thorat, David Ritchie, Andre L Carvalho, Carolina Espina, Ivan Solà, Carlos Canelo‐Aybar, Moira Magdalena Pissinis, Pablo Alonso‐Coello, Ana Carolina Pereira Nunes Pinto   +12 more
wiley   +1 more source

Selective Elimination and Rationalization of Cell-based Assays in Deceased Donor Kidney Transplant Crossmatching. [PDF]

Transplant Direct
Khalili M, Famure O, Minkovich M, Tinckam KJ, Kim SJ.   +4 more
europepmc   +1 more source

A microfabricated dielectrophoretic trapping array for cell-based biological assays

, 2001
Joel Voldman
openalex   +1 more source